{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:40:38Z","timestamp":1768894838274,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1136\/ijgc-2024-005402","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:35:18Z","timestamp":1717371318000},"page":"977-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9295-7008","authenticated-orcid":false,"given":"Theresa M","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5180-0409","authenticated-orcid":false,"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando O","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Awada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9550-3457","authenticated-orcid":false,"given":"Nathalie D","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3121-4605","authenticated-orcid":false,"given":"Robert W","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005402_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164061","article-title":"Role of chemotherapy in vulvar cancers: time to rethink standard of care?","volume":"13","author":"Mazzotta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1136\/ijgc-2024-005402_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","article-title":"Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Koh","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2024-005402_bb0020","first-page":"S76","article-title":"Cancer of the vulva","volume":"131 Suppl. 2","author":"Hacker","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005402_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2020.05.021","article-title":"Locally advanced squamous cell carcinoma of the vulva: a challenging question for gynecologic oncologists","volume":"158","author":"Gadducci","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737140.2015.1037837","article-title":"Systemic treatment of vulvar cancer","volume":"15","author":"Mahner","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1136\/ijgc-2024-005402_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11912-013-0349-x","article-title":"\u201cUnresectable vulval cancers: is neoadjuvant chemotherapy the way forward?","volume":"15","author":"Graham","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1136\/ijgc-2024-005402_bb0040","article-title":"Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy","volume":"44","author":"McCall","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2024-005402_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2021.07.020","article-title":"Phase II study of definitive and chemoradiation for locally advanced squamous cell cancer of the vulva: an efficacy study","volume":"163","author":"van Triest","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1447-0756.2011.01821.x","article-title":"Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: a case report","volume":"38","author":"Achilli","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1136\/ijgc-2024-005402_bb0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/03008916211027627","article-title":"Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience","volume":"108","author":"Adorni","year":"2022","journal-title":"Tumori"},{"key":"10.1136\/ijgc-2024-005402_bb0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/IGC.0b013e3181c93adc","article-title":"Neoadjuvant chemotherapy in advanced vulvar cancer","volume":"20","author":"Domingues","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005402_bb0065","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0b013e318263ef55","article-title":"Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study","volume":"22","author":"Aragona","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005402_bb0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0b013e31824b4058","article-title":"Weekly paclitaxel\/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer","volume":"22","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005402_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3802\/jgo.2014.25.1.22","article-title":"Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva","volume":"25","author":"Raspagliesi","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0080","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011786","article-title":"Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: a STROBE-compliant article","volume":"97","author":"Niu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ijgc-2024-005402_bb0085","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000487435","article-title":"Brief report on 3-weekly paclitaxel carboplatin efficacy in locally advanced or metastatic squamous vulvar cancer","volume":"83","author":"Amant","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1136\/ijgc-2024-005402_bb0090","article-title":"Neoadjuvant chemotherapy with paclitaxel\/carboplatin\/bevacizumab in advanced vulvar cancer: time to rethink standard of care","volume":"34","author":"Klavans","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2024-005402_bb0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/CCO.0000000000000861","article-title":"Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer","volume":"34","author":"Nooij","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0100","article-title":"The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review","volume":"8","author":"Osman","year":"2014","journal-title":"Oncol Rev"},{"key":"10.1136\/ijgc-2024-005402_bb0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.21873\/anticanres.11441","article-title":"Dose-dense paclitaxel- and carboplatin-based neoadjuvant chemotherapy followed by surgery or concurrent chemoradiotherapy in cervical cancer: a preliminary analysis","volume":"37","author":"Gadducci","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2024-005402_bb0110","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005402_bb0115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer - update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005402_bb0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2024-005402_bb0125","first-page":"349","author":"Lee","year":"2015"},{"key":"10.1136\/ijgc-2024-005402_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.prro.2011.12.005","article-title":"Contouring Inguinal and femoral nodes; how much margin is needed around the vessels?","volume":"2","author":"Kim","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2014.08.009","article-title":"Inguinal nodal region radiotherapy for vulvar cancer: are we missing the target again?","volume":"135","author":"Glaser","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0140","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.02235","article-title":"Phase II trial of cisplatin, gemcitabine, and intensity-modulated radiation therapy for locally advanced vulvar squamous cell carcinoma: NRG Oncology\/GOG Study 279","author":"Horowitz","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005402_bb0145","unstructured":"National Comprehensive Cancer Network (NCCN) . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 3.2024. Vulvar Cancer. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/vulvar.pdf [accessed 10 Apr 2024]"},{"key":"10.1136\/ijgc-2024-005402_bb0150","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.12688\/f1000research.110031.1","article-title":"Evaluation of PD-L1 expression in vulvar cancer","volume":"11","author":"Sahraoui","year":"2022","journal-title":"F1000Res"},{"key":"10.1136\/ijgc-2024-005402_bb0155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2024-005402_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:42:42Z","timestamp":1753224162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24014506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1048891X24014506"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005402","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}